P2Y receptors in neuropathic pain

Area of Science:

• Neuroscience
• Pharmacology
• Molecular Biology

Background:

• Purinergic receptors, specifically G protein-coupled P2Y receptors, play a crucial role in neurotransmission.
• These receptors are expressed on various neural cells including neurons, astrocytes, oligodendrocytes, and microglial cells.
• Nerve injury commonly leads to aberrant P2Y receptor mRNA expression, contributing to neuropathic pain.

Purpose of the Study:

• To review and evaluate the association between specific P2Y receptor subtypes (P2Y1, P2Y2, P2Y6, P2Y12, P2Y13) and neuropathic pain.
• To explore current therapeutic strategies for neuropathic pain, focusing on P2Y receptor modulation.
• To identify gaps in current research and suggest future directions for translating basic findings to clinical applications.

Main Methods:

• Comprehensive literature review of studies from inception to 2019.
• Analysis of molecular biological data on P2Y receptor expression and function in neuropathic pain models.
• Evaluation of preclinical evidence for therapeutic interventions targeting P2Y receptors.

Main Results:

• A positive correlation exists between elevated P2Y receptor expression levels and the generation of neuropathic pain.
• P2Y receptor antagonists and P2Y short hairpin RNA (shRNA) demonstrate analgesic effects by reducing receptor expression and neural cell activation.
• The reviewed P2Y receptor subtypes are significantly implicated in the pathophysiology of neuropathic pain.

Conclusions:

• P2Y receptors are key players in the development and maintenance of neuropathic pain.
• Targeting P2Y receptors presents a promising therapeutic avenue for managing neuropathic pain.
• Further research is needed to bridge the gap between preclinical findings and clinical efficacy of P2Y receptor-targeted therapies.